A26S (p.Ala26Ser) variant of FLNA (Filamin-A)
A26S (p.Ala26Ser) in FLNA (Filamin-A) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.
A26S (p.Ala26Ser) variant details
- p.Ala26Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.363
- REVEL 0.26
- CADD 19.10
- PolyPhen-2 0.19
- SIFT 0.52
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available